Related Experiment Video
Updated: May 31, 2025
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
3.9K
Comparative Study of Lipid Profile for Mice Treated with Cyclophosphamide by HPLC-HRMS and Bioinformatics
Ekaterina Demicheva1,2, Fernando Jonathan Polanco Espino1, Pavel Vedeneev3
1Institute of Natural Sciences and Mathematics, Ural Federal University, Ekaterinburg 620075, Russia.
Metabolites
|January 24, 2025
Summary
Researchers identified 15 lipid biomarkers in blood plasma for monitoring immunodeficiency. These metabolic biomarkers show promise for the early diagnosis of immune deficiency diseases.
Area of Science:
- Biochemistry
- Immunology
- Analytical Chemistry
Background:
- Immunodeficiency conditions impair immune activity, leading to chronic diseases.
- Efficient monitoring and early diagnosis of immunodeficiency are crucial.
- Metabolic biomarkers in blood offer a promising avenue for disease detection.
Purpose of the Study:
- To identify lipid biomarkers for monitoring immunodeficiency states.
- To establish potential blood-based markers for early diagnosis of immune deficiency.
Main Methods:
- High-performance liquid chromatography-high-resolution mass spectrometry (HPLC-HRMS) was used to analyze blood plasma samples from mice.
- Bioinformatics approaches were employed for data processing.
- Statistical analysis and MS/MS validation were performed to select potential biomarkers.
Main Results:
- A set of lipid biomarkers associated with immunodeficiency states was identified.
- 15 specific lipids were confirmed as potential biomarkers.
- The identified lipids demonstrated statistical significance and were validated.
Conclusions:
- Fifteen lipids have been confirmed as potential biomarkers for immunodeficiency states.
- These biomarkers represent promising targets for further research.
- The findings support the use of metabolic biomarkers for early immunodeficiency diagnosis.
